Martin Cheever

Affiliations

Cancer Immunotherapy Trials Network, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

Réseau de co-auteurs

Nirasha Ramchurren 2 collaborations

Steven P Fling 2 collaborations

Sylvain Simon 1 collaboration

Valentin Voillet 1 collaboration

Virginie Vignard 1 collaboration

Zhong Wu 1 collaboration

Camille Dabrowski 1 collaboration

Nicolas Jouand 1 collaboration

Tiffany Beauvais 1 collaboration

Amir Khammari 1 collaboration

Cécile Braudeau 1 collaboration

Régis Josien 1 collaboration

Olivier Adotevi 1 collaboration

Caroline Laheurte 1 collaboration

François Aubin 1 collaboration

Charles Nardin 1 collaboration

Samuel Rulli 1 collaboration

Raphael Gottardo 1 collaboration

Candice D Church 1 collaboration

Paul Nghiem 1 collaboration

Brigitte Dreno 1 collaboration

Stanley R Riddell 1 collaboration

Nathalie Labarriere 1 collaboration

Kathryn Lurain 1 collaboration

Ramya Ramaswami 1 collaboration

Ralph Mangusan 1 collaboration

Anaida Widell 1 collaboration

Irene Ekwede 1 collaboration

Jomy George 1 collaboration

Richard Ambinder 1 collaboration

James L Gulley 1 collaboration

Priscila H Goncalves 1 collaboration

Hao-Wei Wang 1 collaboration

Thomas S Uldrick 1 collaboration

Robert Yarchoan 1 collaboration

Russell K Pachynski 1 collaboration

Chihiro Morishima 1 collaboration

Russell Szmulewitz 1 collaboration

Lauren Harshman 1 collaboration

Leonard Appleman 1 collaboration

Paul Monk 1 collaboration

Rhonda L Bitting 1 collaboration

Omer Kucuk 1 collaboration

Frederick Millard 1 collaboration

John D Seigne 1 collaboration

Holden T Maecker 1 collaboration

Caroline Duault 1 collaboration

Bruce Hess 1 collaboration

Leonard D'Amico 1 collaboration

Andreanne Lacroix 1 collaboration

Judith C Kaiser 1 collaboration

Michel Morre 1 collaboration

Anne Grégoire 1 collaboration

Evan Y Yu 1 collaboration

Lawrence Fong 1 collaboration

Martin Cheever

Affiliations

Publications (3)

PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy.

Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin's lymphoma.

IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC).

Réseau de co-auteurs